PharmiWeb1h
Boston Scientific announces agreement to acquire SoniVie Ltd.
Boston Scientific Corporation (NYSE: BSX) today announced it has entered into a definitive agreement to acquire SoniVie Ltd., ...
PharmiWeb2h
Stryker launches Sync Badge
Stryker (NYSE:SYK), a global leader in medical technologies, announced the launch of the Sync Badge, a hands-free, wearable device designed to enhance communication and collaboration in the fast-paced ...
PharmiWeb2h
Protagonist and Takeda Announce Positive Topline Results from Phase 3 VERIFY Study of Rusfertide in Patients with Polycythemia Vera
Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) today announced positive topline results for the Phase 3 VERIFY study, in which phlebotomy-dependent ...
PharmiWeb2h
AbbVie and Gubra Announce License Agreement to Develop an Amylin Analog for the Treatment of Obesity
AbbVie (NYSE: ABBV) and Gubra A/S (CPSE:GUBRA), a company specializing in preclinical contract research services and peptide-based drug discovery within metabolic and fibrotic diseases, today ...
PharmiWeb2h
Imfinzi-based perioperative regimen recommended for approval in the EU by CHMP for resectable non-small cell lung cancer
AstraZeneca’s Imfinzi (durvalumab) in combination with chemotherapy has been recommended for approval in the European Union (EU) for the treatment of adults with resectable non-small cell lung cancer ...
PharmiWeb2h
Evotec Announces Key Progress in Neuroscience Collaboration with Bristol Myers Squibb
Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) today announced another major accomplishment in its long-standing neuroscience collaboration with Bristol Myers ...
PharmiWeb2h
Eisai Receives Regulatory Review Outcome for Lecanemab as a Treatment for Early Alzheimer’s Disease in Australia
Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, “Biogen”) announced ...
PharmiWeb3h
Dermal Fillers Market Size to Register USD 8.75 Billion Globally, by 2030, at 9.10% CAGR Growth
Global Dermal Fillers Market is valued at USD 4.36 Billion in 2022. Global Dermal Fillers Market valuation to reach USD 8.75 ...
PharmiWeb3h
Breath Analyzers Market Size to Register USD 3.6 Billion Globally, by 2030, at 15.7% CAGR Growth
Global Breath Analyzers Market is valued at USD 1.3 Billion in 2022. Global Breath Analyzers Market valuation to reach USD ...
PharmiWeb3h
Healthcare Biometrics Market Size to Register USD 55.4 Billion Globally, by 2035, at 23.7% CAGR Growth
Global Healthcare Biometrics Market is valued at USD 10.1 Billion in 2024. Global Healthcare Biometrics Market valuation to ...
PharmiWeb3h
Advancements in Biopharmaceutical Preservation to Propel Lyophilization Equipment and Services Market Beyond $13.47 Bn by 2034 | TMR Analysis
The global Lyophilization Equipment and Services Market, a cornerstone of pharmaceutical, biotechnology, and food ...
PharmiWeb3h
Regulatory expert named keynote speaker and panel chair for ‘key Scottish life sciences event’ this March
InnoScot Health’s regulatory expert will have a dual role as keynote speaker and panel chair during a new conference segment celebrating the 25th anniversary of Scotland’s Life Sciences Awards.The ...